Amoxicillin
FDA-approved product (capsule, oral), marketed as Amoxicillin, Amoxicillin Pediatric, Amoxil and 7 more.
- Registered studies
- 50+
- Lab records
- 107
- Pathogens at ≥40%
- 1 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Bacterial disease
- Duodenal ulcer
- Gonorrhea
- Infection
- Infectious otitis media
- Otitis media
- Pharyngitis
- Pneumonia
- Recurrent tonsillitis
- Respiratory tract infectious disorder
- Sinusitis
- Soft Tissue Infections
- Tonsillitis
- Urinary tract infection
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Penicillins with extended spectrum
- Anti-infective classification
- Classified as an existing antimicrobial.WHO ATC J01CA04
Repurposing investigation
Amoxicillin is already an antimicrobial, so it is not counted among the repurposing candidates. Its AI-predicted activity is shown below for reference.
AI-predicted activity
AI prediction · nothing measured- MRSA85.5% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- E. coli30.1% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- K. pneumoniae5.9% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- M. tuberculosis33.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
- MRSA: measured active in 20 of 26 lab records
- E. coli: measured active in 5 of 10 lab records
- K. pneumoniae: measured active in 3 of 71 lab records
Show the 107 laboratory records, with sources
Loading records…
“Active” means the measured value reached this project’s laboratory cutoff (10 µM or stronger). A laboratory result does not show an effect in patients.
Docking
Computational · nothing measuredAutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Amoxicillin with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Ozanimod HydrochlorideExisting use: Multiple sclerosis, Relapsing-remitting multiple sclerosis, Ulcerative colitis66.8% AI-predicted activityagainst MRSA7 registered studies
- Micafungin SodiumExisting use: Candidiasis66.8% AI-predicted activityagainst MRSA50+ registered studies
- AbemaciclibExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 3 more66.4% AI-predicted activityagainst MRSA50+ registered studies
- RisperidoneExisting use: Aggressive behavior, Autism, Bipolar disorder and 4 more66.4% AI-predicted activityagainst MRSA50+ registered studies
- Lazertinib MesylateExisting use: Non-small cell lung carcinoma66.1% AI-predicted activityagainst MRSANo documented evidence found
- Desmopressin AcetateExisting use: Central diabetes insipidus, Diabetes insipidus, Enuresis and 5 more65.8% AI-predicted activityagainst MRSA50+ registered studies
- Terazosin HydrochlorideExisting use: Benign prostatic hyperplasia65.8% AI-predicted activityagainst MRSA41 registered studies
- VemurafenibExisting use: Cancer, Cutaneous melanoma, Melanoma and 2 more65.8% AI-predicted activityagainst MRSA50+ registered studies
- Caspofungin AcetateExisting use: Aspergillosis, Candidemia, Candidiasis and 1 more65.5% AI-predicted activityagainst MRSA50+ registered studies
- VenetoclaxExisting use: Cancer, Chronic lymphocytic leukemia, Neoplasm65.5% AI-predicted activityagainst MRSA50+ registered studies
- Larotrectinib SulfateExisting use: Abdominal Neoplasms, Cancer, Metastasis and 1 more65.4% AI-predicted activityagainst MRSA5 registered studies
- SirolimusExisting use: Adenoma sebaceum, Angiofibroma, Cancer and 5 more65.2% AI-predicted activityagainst MRSA50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone
NCT02281929 · start 2015-06-13
Registered record
- Registry ID
- NCT02281929
- Conditions
- Alcoholic Hepatitis; Alcoholic Liver Disease
- Interventions
- Amoxicillin; Placebo; Prednisolone
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2015-06-13
- Completion
- 2019-11-19
- Enrolment
- 297
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAlcoholic Hepatitis; Alcoholic Liver DiseaseInterventionAmoxicillin; Placebo; PrednisolonePhasePhase 3Registry statusCompletedPreschool Wheeze: Inflammation/Infection Guided Management
NCT02517099 · start 2015-06-05
Registered record
- Registry ID
- NCT02517099
- Conditions
- Asthma
- Interventions
- Beclometasone; Co-amoxiclav; Azithromycin
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2015-06-05
- Completion
- 2018-08-17
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAsthmaInterventionBeclometasone; Co-amoxiclav; AzithromycinPhasePhase 2Registry statusCompletedTwo Versus Four Weeks of Antibiotic Treatment in Native Joint Arthritis
NCT03615781 · start 2015-06-01
Registered record
- Registry ID
- NCT03615781
- Conditions
- Arthritis, Septic
- Interventions
- Two week's arm - surgery; Four week's arm - surgery; Two week's arm - drugs; Four week's arm - drugs
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2015-06-01
- Completion
- 2018-05-18
- Enrolment
- 85
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionArthritis, SepticInterventionTwo week's arm - surgery; Four week's arm - surgery; Two week's arm - drugs; Four week's arm - drugsPhaseNot applicableRegistry statusCompletedResearchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
NCT05553743 · start 2014-03-27
Registered record
- Registry ID
- NCT05553743
- Conditions
- Breastfeeding; COVID-19 Infection; COVID-19 Vaccine; Remdesivir; Antibiotics
- Interventions
- COVID-19 Exposure; Antibiotic
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2014-03-27
- Completion
- 2040-03
- Enrolment
- 5,000
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBreastfeeding; COVID-19 Infection; COVID-19 Vaccine; Remdesivir +1 moreInterventionCOVID-19 Exposure; AntibioticPhaseNot recordedRegistry statusRecruitingA Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide
NCT02090738 · start 2014-03
Registered record
- Registry ID
- NCT02090738
- Conditions
- H. Pylori Infection
- Interventions
- Acetazolamide group; Standard regimen group
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Withdrawn
- Start
- 2014-03
- Completion
- Not recorded
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionH. Pylori InfectionInterventionAcetazolamide group; Standard regimen groupPhasePhase 2Registry statusWithdrawnPhase I Study of Safety and Immunogenicity of ADU-623
NCT01967758 · start 2014-01-08
Registered record
- Registry ID
- NCT01967758
- Conditions
- Astrocytic Tumors; Glioblastoma Multiforme; Anaplastic Astrocytoma; Brain Tumor
- Interventions
- Cohort 1; Cohort 2; Cohort 3; Antibiotics
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2014-01-08
- Completion
- 2018-08-15
- Enrolment
- 11
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAstrocytic Tumors; Glioblastoma Multiforme; Anaplastic Astrocytoma; Brain TumorInterventionCohort 1; Cohort 2; Cohort 3; AntibioticsPhasePhase 1Registry statusCompletedA Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ Clavulanate
NCT01491659 · start 2013-01
Registered record
- Registry ID
- NCT01491659
- Conditions
- Diarrhoea
- Interventions
- Idoform Plus; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Withdrawn
- Start
- 2013-01
- Completion
- 2013-03
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDiarrhoeaInterventionIdoform Plus; PlaceboPhasePhase 4Registry statusWithdrawnUse of Probiotic Lactobacilli for the Treatment of Lactational Mastitis
NCT00716183 · start 2008-07
Registered record
- Registry ID
- NCT00716183
- Conditions
- Mastitis
- Interventions
- Lactobacillus salivarius HN6; Lactobacillus reuteri CR20; Lactobacillus fermentum LC40; Beta-lactam antibiotic
- Study type
- INTERVENTIONAL
- Phase
- Phase 2 / Phase 3
- Registry status
- Completed
- Start
- 2008-07
- Completion
- 2009-05
- Enrolment
- 300
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMastitisInterventionLactobacillus salivarius HN6; Lactobacillus reuteri CR20; Lactobacillus fermentum LC40; Beta-lactam antibioticPhasePhase 2 / Phase 3Registry statusCompletedAntibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures
NCT01524081 · start 2008-07
Registered record
- Registry ID
- NCT01524081
- Conditions
- Acute Appendicitis; Perforated Gastroduodenal Ulcer; Small Bowel Obstruction
- Interventions
- Metronidazole, Cefuroxime; Amoxicillin (+ clavulanic acid) and Fluconazole; Placebo; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2008-07
- Completion
- 2011-11
- Enrolment
- 187
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAcute Appendicitis; Perforated Gastroduodenal Ulcer; Small Bowel ObstructionInterventionMetronidazole, Cefuroxime; Amoxicillin (+ clavulanic acid) and Fluconazole; Placebo; PlaceboPhasePhase 3Registry statusCompletedSpecial Drug Use Investigation for CLAVAMOX® (Amoxicillin/Clavulanate) Pediatrics Dry Syrup (Every Indication Excluded Otitis Media)
NCT01406275 · start 2008-01
Registered record
- Registry ID
- NCT01406275
- Conditions
- Otitis Maedia
- Interventions
- Amoxicillin and clavulanate
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2008-01
- Completion
- 2008-12
- Enrolment
- 363
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOtitis MaediaInterventionAmoxicillin and clavulanatePhaseNot recordedRegistry statusCompletedMiddle Meatal Bacteriology During Acute Respiratory Infection in Children
NCT00545961 · start 2007-11
Registered record
- Registry ID
- NCT00545961
- Conditions
- Acute Respiratory Infection; Sinusitis
- Interventions
- placebo; amoxicillin clavulanate acid
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2007-11
- Completion
- 2009-12
- Enrolment
- 120
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAcute Respiratory Infection; SinusitisInterventionplacebo; amoxicillin clavulanate acidPhasePhase 4Registry statusUnknownZmax Compared to Augmentin in Sinusitis
NCT00367120 · start 2006-06
Registered record
- Registry ID
- NCT00367120
- Conditions
- Sinusitis
- Interventions
- Azithromycin Extended Release; Amoxicillin/Clavulanate
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2006-06
- Completion
- 2007-02
- Enrolment
- 762
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSinusitisInterventionAzithromycin Extended Release; Amoxicillin/ClavulanatePhasePhase 4Registry statusCompletedAmoxicillin and Metronidazole in Association With Non-surgical Therapy in Aggressive Periodontitis Treatment
NCT03933501 · start 2006-01-01
Registered record
- Registry ID
- NCT03933501
- Conditions
- Generalized Aggressive Periodontitis
- Interventions
- amoxicillin and metronidazole; Placebos
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2006-01-01
- Completion
- 2018-12-01
- Enrolment
- 48
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionGeneralized Aggressive PeriodontitisInterventionamoxicillin and metronidazole; PlacebosPhasePhase 4Registry statusCompletedGuidelines for Acute Sinusitis
NCT00132275 · start 2003-11
Registered record
- Registry ID
- NCT00132275
- Conditions
- Sinusitis
- Interventions
- Amoxicillin potassium clavulanate
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2003-11
- Completion
- 2006-08
- Enrolment
- 240
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSinusitisInterventionAmoxicillin potassium clavulanatePhaseNot applicableRegistry statusCompletedEffect of Three Periodontal Therapies in Current Smokers and Non-Smokers
NCT00066066 · start 2003-07
Registered record
- Registry ID
- NCT00066066
- Conditions
- Periodontitis; Periodontal Diseases
- Interventions
- Scaling and root planing; Metronidazole; Amoxicillin; Doxycycline
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2003-07
- Completion
- 2009-07
- Enrolment
- 146
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPeriodontitis; Periodontal DiseasesInterventionScaling and root planing; Metronidazole; Amoxicillin; DoxycyclinePhasePhase 2Registry statusCompleted